Academic literature on the topic 'Dermonecrotic toxin'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Dermonecrotic toxin.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Dermonecrotic toxin"

1

Chaim, Olga Meiri, Youssef Bacila Sade, Rafael Bertoni da Silveira, et al. "Brown spider dermonecrotic toxin directly induces nephrotoxicity." Toxicology and Applied Pharmacology 211, no. 1 (2006): 64–77. http://dx.doi.org/10.1016/j.taap.2005.05.015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Horiguchi, Yasuhiko. "Escherichia coli cytotoxic necrotizing factors and Bordetella dermonecrotic toxin: the dermonecrosis-inducing toxins activating Rho small GTPases." Toxicon 39, no. 11 (2001): 1619–27. http://dx.doi.org/10.1016/s0041-0101(01)00149-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Horiguchi, Yasuhiko, Toyotsugu Nakai, and Katsumi Kume. "Purification and characterization of Bordetella bronchiseptica dermonecrotic toxin." Microbial Pathogenesis 6, no. 5 (1989): 361–68. http://dx.doi.org/10.1016/0882-4010(89)90078-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Buys, W. E. C. M., H. E. Smith, A. M. I. E. Kamps, E. M. Kamp, and M. A. Smits. "Sequence of the dermonecrotic toxin ofPasteurella multocida ssp. multocida." Nucleic Acids Research 18, no. 9 (1990): 2815–16. http://dx.doi.org/10.1093/nar/18.9.2815.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Okada, Keisuke, Hiroyuki Abe, Fumio Ike, et al. "Polymorphisms Influencing Expression of Dermonecrotic Toxin in Bordetella bronchiseptica." PLOS ONE 10, no. 2 (2015): e0116604. http://dx.doi.org/10.1371/journal.pone.0116604.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Fukui-Miyazaki, Aya, Shigeki Kamitani, Masami Miyake, and Yasuhiko Horiguchi. "Association of Bordetella dermonecrotic toxin with the extracellular matrix." BMC Microbiology 10, no. 1 (2010): 247. http://dx.doi.org/10.1186/1471-2180-10-247.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kimman, T. G., C. W. Löwik, L. J. van de Wee-Pals, et al. "Stimulation of bone resorption by inflamed nasal mucosa, dermonecrotic toxin-containing conditioned medium from Pasteurella multocida, and purified dermonecrotic toxin from P. multocida." Infection and Immunity 55, no. 9 (1987): 2110–16. http://dx.doi.org/10.1128/iai.55.9.2110-2116.1987.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Magyar, T., R. Glávits, G. D. Pullinger, and A. J. Lax. "The Pathological Effect of the Bordetella Dermonecrotic Toxin in Mice." Acta Veterinaria Hungarica 48, no. 4 (2000): 397–406. http://dx.doi.org/10.1556/004.48.2000.4.3.

Full text
Abstract:
The effect of dermonecrotic toxin (DNT) expression of Bordetella bronchiseptica was studied in mice by comparing the pathology induced by a wild type strain with that induced by an isogenic DNT- strain in which part of the structural gene has been replaced by an antibiotic resistance cassette. While extracts of strain B58 proved toxic in intravenously inoculated mice, similar extracts from strain B58GP had lost toxic activity. The parent (B58) and the mutant (B58GP) strains of B. bronchiseptica each possessed comparable virulence for mice. These findings confirmed that DNT production was successfully abolished in strain B58GP while other virulence characteristics required for pathogenicity in mice remained intact, at a comparable level to the parent strain. Turbinate atrophy was observed in mice infected with the DNT+ strain, but not in those infected with the DNT-strain. This indicates that DNT is the cause of turbinate atrophy in the mice and not other factors produced by phase I strains of B. bronchiseptica. B. bronchiseptica DNT showed a lienotoxic effect (lymphocyte depletion and a reduction in the intensity of extramedullar haemocytopoieis) that is considered to adversely alter the immune function of the host animal. In mice infected with strain B58GP, catarrhal pneumonia with characteristic lympho-histiocytic peribronchial and perivascular infiltration was noticed. In mice infected with strain B58, large necrotic areas were seen surrounded by an inflammatory reaction. The DNT appears to directly damage lung tissues, at least in mice. DNT production seems to enhance the establishment of B. bronchiseptica in the lungs, presumably by reducing the local resistance and causing severe local damage to the lung tissues.
APA, Harvard, Vancouver, ISO, and other styles
9

Borchani, Lamia, Atfa Sassi, Delavar Shahbazzadeh, et al. "Heminecrolysin, the first hemolytic dermonecrotic toxin purified from scorpion venom." Toxicon 58, no. 1 (2011): 130–39. http://dx.doi.org/10.1016/j.toxicon.2011.05.016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Matsuzawa, Takeshi, Takashige Kashimoto, Jun Katahira, and Yasuhiko Horiguchi. "Identification of a Receptor-Binding Domain of Bordetella Dermonecrotic Toxin." Infection and Immunity 70, no. 7 (2002): 3427–32. http://dx.doi.org/10.1128/iai.70.7.3427-3432.2002.

Full text
Abstract:
ABSTRACT Bordetella dermonecrotic toxin (DNT) stimulates the assembly of actin stress fibers and focal adhesions by deamidating or polyaminating Gln63 of the small GTPase Rho. DNT is an A-B toxin which is composed of an N-terminal receptor-binding (B) domain and a C-terminal enzymatically active (A) domain. In this study, to analyze the functional and structural organization of DNT, we prepared 10 clones of hybridoma producing anti-DNT monoclonal antibodies. One of these antibodies, 2B3, neutralized the effects of DNT on target cells when mixed with the toxin. When microinjected into cells, however, 2B3 did not inhibit the intoxication by DNT. Western blot analysis revealed that 2B3 recognized the N-terminal region of DNT. To delineate the DNT-binding domain, we examined a series of truncated DNT mutants for the ability to competitively inhibit the intoxication of cells by the full-length DNT and found that a fragment consisting of the N-terminal 54 amino acids (DNT1-54) was the smallest inhibitory fragment. The radioiodinated DNT1-54 actually bound to target cells, which was inhibited by 2B3. These results suggest that the N-terminal 54 amino acids of DNT are responsible for the binding to target cells. DNT1-54 bound to none of the DNT-resistant cells, implying the presence of a cell surface receptor specific to DNT-sensitive cells.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Dermonecrotic toxin"

1

Adams, Toni Elizabeth. "Bordetella bronchiseptica dermonecrotic toxin, purification and characterisation." Thesis, University of Leicester, 1997. http://hdl.handle.net/2381/29723.

Full text
Abstract:
Dermonecrotic toxin (DNT) is produced by all the Bordetella species, and DNT from B. bronchiseptica is considered to be an important virulence factor in turbinate atrophy of pigs.;Recombinant DNT (rDNT) was purified by sonication, ion-exchange and hydroxylapatite chromatography. Other methods for the purification of wild-type DNT and rDNT, including preparative isoelectric focusing and hydrophobic chromatography, were investigated in detail.;Partially pure preparations of rDNT contained a 145 kDa protein band and were cytotoxic to embryonic bovine lung (EBL) cells. Partially pure rDNT induced the formation of actin stress fibres and focal adhesions in Swiss 3T3 cells. In addition, rDNT stimulated DNA synthesis in quiescent Swiss 3T3 cells but prevented cell proliferation, resulting in binucleated cells. Recombinant DNT has been shown to directly modify the small GTP-binding protein, Rho, (Pullinger, unpublished), which regulates the cell cytoskeleton. Results from this thesis indicate that rDNT causes the assembly of actin stress fibres and focal adhesion possibly by direct activation of the Rho protein.;Partially purified rDNT with a site-directed mutation in a putative nucleotide-binding motif did not induce cytoskeletal rearrangements and did not stimulate DNA synthesis in Swiss 3T3 cells. This suggests that the nucleotide-binding motif is essential for activity.;Two lines of evidence indicate that the toxin is internalised in the endosomal/lysosomal compartment: i) stimulation of DNA synthesis by transient exposure of Swiss 3T3 cells to rDNT, and ii) blocking of rDNT-induced DNA synthesis with methylamine.;Three monoclonal antibodies (mAbs) were produced against B. bronchiseptica DNT. These mAbs recognised rDNT and B. pertussis DNT, but none neutralised the cytotoxic activity of DNT on EBL cells.;The partial purification of rDNT and characterisation of its biological effects provide valuable information for further studies of the toxin, including analysis of its enzymatic mode of action and its role in infection. Also, DNT may prove to be a useful tool for analysis of cell responses involving the important signalling molecule, Rho.
APA, Harvard, Vancouver, ISO, and other styles
2

Garrod, Tracey. "Partial purification and characterisation of Bordetella bronchiseptica dermonecrotic toxin." Thesis, University of Reading, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.239514.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Omsland, Anders. "Antimicrobial Effects of Reactive Nitrogen Species and Reactive Oxygen Species on Bordetella and a Role for Dermonecrotic Toxin in Bacterial Physiology." Diss., The University of Arizona, 2005. http://hdl.handle.net/10150/194233.

Full text
Abstract:
Bordetella species express virulence factors that enable host immune evasion and establishment of prolonged respiratory infection. Upon interaction with ciliated cells of the host upper airway, bordetellae are subjected to antimicrobial reactive nitrogen species (RNS) and reactive oxygen species (ROS) as part of the host innate immune defense. I hypothesized that RNS and ROS have anti-Bordetella activity at physiologically relevant concentrations. In a novel in vitro assay, B. bronchiseptica exposure to prototypical redox active species revealed toxicity at physiologically relevant (nM-μM) concentrations. Antimicrobial synergy was observed when individual redox active species were applied in combination. Additionally, there was increased bacteriostatic activity of nitric oxide towards Bordetella relative to hydrogen peroxide. Analysis of B. bronchiseptica mutant strains unable to respond to physiological stimuli via the two-component virulence control system BvgAS identified a protective role for BvgAS in the Bordetella redox stress response. The observation that RNS and ROS produced by airway epithelial cells have anti-Bordetella activity at physiologically relevant concentrations encourages further analysis of how manipulation of redox active species in the airway can be utilized to combat airway infection. Species of the Bordetella genus express a conserved virulence factor, dermonecrotic toxin (DNT), that in purified form can target host cell cytoskeletal regulators. However, DNT is not released from cultured bacteria, and no mechanism for bacteria to host transfer has been described. I hypothesized that loss of DNT expression affects bacterial physiological processes. Comparison of wild type B. bronchiseptica and a DNT mutant strain revealed an altered proteome that included several proteins associated with bacterial metabolism. In vitro, loss of DNT expression resulted in increased sensitivity to physiological stress. Comparison of wild type and DNT mutant B. bronchiseptica interactions with primary cultured rabbit tracheal epithelial cells did not reveal a function for DNT in host cell actin cytoskeletal rearrangement during the B. bronchiseptica-host interaction. It is suggested that DNT is conserved across the Bordetella genus because of its effects on bacterial physiology. This is a novel perspective on a Bordetella factor under BvgAS control and may have implications for understanding similar necrotizing factors from other virulent bacteria.
APA, Harvard, Vancouver, ISO, and other styles
4

Bočková, Barbora. "Konstrukce geneticky detoxifikovaného kmene Bordetella pertussis pro výrobu nové generace celobuněčné vakcíny." Master's thesis, 2016. http://www.nusl.cz/ntk/nusl-343090.

Full text
Abstract:
Bordetella pertussis is a strictly human pathogen colonizing the upper respiratory tract, causing a respiratory disease known as whooping cough or pertussis. The introduction of whole-cell vaccines and acellular vaccines, resulted in a significant reduction in the incidence of disease and reduce the fatalities associated with infection. However, epidemiological data show a significant increase in the incidence of the disease in recent decades. The increasing incidence is mainly attributed to the transition from the whole- cell vaccine to an acellular vaccine. Based on research from recent years has shown that acellular vaccines have many drawbacks, and it is therefore necessary to change the vaccination strategy. One possible solution to the situation is the development of a new generation of whole-cell vaccines with reduced reactogenicity. The new whole-cell vaccine was prepared by a genetically modified B. pertussis strain. B. pertussis was modified using allelic exchange to develop strain encoding enzymatically inactive pertussis toxin, modified lipid A and lacking dermonecrotic toxin. This combination of genetic modifications in mice led to a decrease in reactogenicity test vaccine in vivo. In case of intranasal infection whole-cell vaccine containing genetically modified strain is providing...
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Dermonecrotic toxin"

1

Horiguchi, Yasuhiko. "Swine Atrophic Rhinitis Caused by Pasteurella multocida Toxin and Bordetella Dermonecrotic Toxin." In Current Topics in Microbiology and Immunology. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/82_2012_206.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Schmidt, Gudula, and Klaus Aktories. "Rho GTPase-activating toxins: Cytotoxic necrotizing factors and dermonecrotic toxin." In Methods in Enzymology. Elsevier, 2000. http://dx.doi.org/10.1016/s0076-6879(00)25437-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ownby, Charlotte L. "Locally Acting Agents: Myotoxins, Hemorrhagic Toxins and Dermonecrotic Factors." In Handbook of Toxinology. CRC Press, 2020. http://dx.doi.org/10.1201/9781003066538-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!